Verastem, Inc. Payments to Acquire Investments
Verastem, Inc. (VSTM) reported Payments to Acquire Investments of $60.22 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2016-11-07
- Verastem, Inc. payments to acquire investments for the quarter ending 2016-09-30 was $19.82M, a 64.71% decline year-over-year.
- Verastem, Inc. payments to acquire investments for the quarter ending 2016-06-30 was $4.05M, a 76.17% decline year-over-year.
- Verastem, Inc. payments to acquire investments for the quarter ending 2016-03-31 was $36.35M, a 53.60% decline year-over-year.
- Verastem, Inc. payments to acquire investments for the quarter ending 2015-12-31 was $48.35M, a 611.97% increase year-over-year.
- Verastem, Inc. payments to acquire investments for fiscal 2015 was $199.85M, a 407.74% increase from fiscal 2014.
- Verastem, Inc. payments to acquire investments for fiscal 2014 was $39.36M, a 66.70% decline from fiscal 2013.
- Verastem, Inc. payments to acquire investments for fiscal 2013 was $118.19M, a 23.27% decline from fiscal 2012.
- Verastem, Inc. payments to acquire investments for fiscal 2012 was $154.03M, a 329.63% increase from fiscal 2011.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month | Payments to Acquire Investments 20 month | Payments to Acquire Investments 23 month | Payments to Acquire Investments 26 month | Payments to Acquire Investments 29 month | Payments to Acquire Investments 32 month | Payments to Acquire Investments 35 month | Payments to Acquire Investments 38 month | Payments to Acquire Investments 41 month | Payments to Acquire Investments 44 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | $19.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $23.88M derived: sum of 2 quarters · filed 2016-11-07 | $60.22M 10-Q · filed 2016-11-07 | $108.57M derived: sum of 4 quarters · filed 2016-11-07 | |||||||||
| 2016-06-30 | $4.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $40.40M 10-Q · filed 2016-08-08 | $88.75M derived: sum of 3 quarters · filed 2016-08-08 | $144.92M derived: sum of 4 quarters · filed 2016-11-07 | |||||||||
| 2016-03-31 | $36.35M 10-Q · filed 2016-05-09 | $84.70M derived: sum of 2 quarters · filed 2016-05-09 | $140.86M derived: sum of 3 quarters · filed 2016-11-07 | $157.87M derived: sum of 4 quarters · filed 2016-11-07 | |||||||||
| 2015-12-31 | $48.35M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $104.52M derived: sum of 2 quarters · filed 2016-11-07 | $121.53M derived: sum of 3 quarters · filed 2016-11-07 | $199.85M 10-K · filed 2016-03-03 | |||||||||
| 2015-09-30 | $56.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $73.17M derived: sum of 2 quarters · filed 2016-11-07 | $151.50M 10-Q · filed 2016-11-07 | $158.29M derived: sum of 4 quarters · filed 2016-11-07 | |||||||||
| 2015-06-30 | $17.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $95.33M 10-Q · filed 2016-08-08 | $102.12M derived: sum of 3 quarters · filed 2016-08-08 | $108.05M derived: sum of 4 quarters · filed 2016-08-08 | |||||||||
| 2015-03-31 | $78.33M 10-Q · filed 2016-05-09 | $85.12M derived: sum of 2 quarters · filed 2016-05-09 | $91.05M derived: sum of 3 quarters · filed 2016-05-09 | $108.52M derived: sum of 4 quarters · filed 2016-05-09 | |||||||||
| 2014-12-31 | $6.79M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $12.72M derived: sum of 2 quarters · filed 2016-03-03 | $30.19M derived: sum of 3 quarters · filed 2016-03-03 | $39.36M 10-K · filed 2016-03-03 | |||||||||
| 2014-09-30 | $5.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $23.40M derived: sum of 2 quarters · filed 2015-11-09 | $32.57M 10-Q · filed 2015-11-09 | $47.40M derived: sum of 4 quarters · filed 2016-03-03 | |||||||||
| 2014-06-30 | $17.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $26.64M 10-Q · filed 2015-08-10 | $41.47M derived: sum of 3 quarters · filed 2016-03-03 | $100.62M derived: sum of 4 quarters · filed 2016-03-03 | |||||||||
| 2014-03-31 | $9.17M 10-Q · filed 2015-05-11 | $24.00M derived: sum of 2 quarters · filed 2016-03-03 | $83.15M derived: sum of 3 quarters · filed 2016-03-03 | $100.14M derived: sum of 4 quarters · filed 2016-03-03 | $317.24M 10-Q · filed 2014-05-08 | ||||||||
| 2013-12-31 | $14.83M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $73.98M derived: sum of 2 quarters · filed 2016-03-03 | $90.97M derived: sum of 3 quarters · filed 2016-03-03 | $118.19M 10-K · filed 2016-03-03 | $308.07M 10-K · filed 2014-03-06 | ||||||||
| 2013-09-30 | $59.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $76.14M derived: sum of 2 quarters · filed 2014-10-30 | $103.36M 10-Q · filed 2014-10-30 | $111.48M derived: sum of 4 quarters · filed 2015-03-10 | $293.24M 10-Q · filed 2013-11-12 | ||||||||
| 2013-06-30 | $16.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $44.21M 10-Q · filed 2014-08-07 | $52.33M derived: sum of 3 quarters · filed 2015-03-10 | $81.31M derived: sum of 4 quarters · filed 2015-03-10 | $234.09M 10-Q · filed 2013-08-13 | ||||||||
| 2013-03-31 | $27.22M 10-Q · filed 2014-05-08 | $35.34M derived: sum of 2 quarters · filed 2015-03-10 | $64.32M derived: sum of 3 quarters · filed 2015-03-10 | $108.49M derived: sum of 4 quarters · filed 2015-03-10 | $217.10M 10-Q · filed 2013-05-09 | ||||||||
| 2012-12-31 | $8.12M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-10 | $37.10M derived: sum of 2 quarters · filed 2015-03-10 | $81.27M derived: sum of 3 quarters · filed 2015-03-10 | $154.03M 10-K · filed 2015-03-10 | $189.88M 10-K · filed 2013-03-26 | ||||||||
| 2012-09-30 | $28.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $73.15M derived: sum of 2 quarters · filed 2013-11-12 | $145.91M 10-Q · filed 2013-11-12 | $181.76M 10-Q · filed 2012-11-13 | |||||||||
| 2012-06-30 | $44.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $116.92M 10-Q · filed 2013-08-13 | $152.77M 10-Q · filed 2012-08-13 | ||||||||||
| 2012-03-31 | $72.76M 10-Q · filed 2013-05-09 | $108.61M 10-Q · filed 2012-05-14 | |||||||||||
| 2011-12-31 | $35.85M 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |